Mackay Shields LLC Fibrogen Inc Transaction History

Mackay Shields LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$18.57 - $35.68 $773,589 - $1.49 Million	-41,658 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $636,957 - $1.14 Million	-20,547 Reduced 33.03%	41,658 $1.45 Million
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $81,598 - $107,734	-2,200 Reduced 3.42%	62,205 $2.31 Million
Q3 2020 Nov 04, 2020	SELL	$40.47 - $45.5 $210,444 - $236,600	-5,200 Reduced 7.47%	64,405 $2.65 Million
Q2 2020 Jul 31, 2020	BUY	$32.57 - $42.83 $371,298 - $488,262	11,400 Added 19.59%	69,605 $2.82 Million
Q1 2020 May 08, 2020	BUY	$23.3 - $45.96 $51,260 - $101,112	2,200 Added 3.93%	58,205 $2.02 Million
Q4 2019 Feb 11, 2020	SELL	$34.58 - $48.06 $72,618 - $100,926	-2,100 Reduced 3.61%	56,005 $2.4 Million
Q3 2019 Nov 01, 2019	SELL	$36.98 - $48.45 $40,678 - $53,295	-1,100 Reduced 1.86%	58,105 $2.15 Million
Q2 2019 Aug 13, 2019	BUY	$35.13 - $55.53 $1.26 Million - $1.99 Million	35,847 Added 153.47%	59,205 $2.67 Million
Q1 2019 May 13, 2019	SELL	$42.83 - $59.91 $12,849 - $17,973	-300 Reduced 1.27%	23,358 $1.27 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $191,065 - $302,725	-5,032 Reduced 17.54%	23,658 $1.1 Million
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $332,170 - $396,775	5,900 Added 25.89%	28,690 $1.74 Million
Q2 2018 Aug 06, 2018	SELL	$44.9 - $64.95 $26,940 - $38,970	-600 Reduced 2.57%	22,790 $1.43 Million
Q1 2018 May 03, 2018	BUY	$45.35 - $61.65 $1.06 Million - $1.44 Million	23,390 New	23,390 $1.08 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.